Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 4/20 | 0.52 |
| ▸ | GAA | P10253 | 4/20 | 0.52 |
| ▸ | SI | P14410 | 4/20 | 0.52 |
| ▸ | MGAM2 | Q2M2H8 | 4/20 | 0.52 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.45 |
| ▸ | PRKD3 | O94806 | 2/20 | 0.45 |
| ▸ | ABL1 | P00519 | 2/20 | 0.45 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.45 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.45 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.45 |
| ▸ | LCK | P06239 | 1/20 | 0.45 |
| ▸ | FYN | P06241 | 1/20 | 0.45 |
| ▸ | CSF1R | P07333 | 1/20 | 0.45 |
| ▸ | RET | P07949 | 1/20 | 0.45 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.45 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.45 |
| ▸ | LTK | P29376 | 1/20 | 0.45 |
| ▸ | GRK5 | P34947 | 1/20 | 0.45 |
| ▸ | KDR | P35968 | 1/20 | 0.45 |
| ▸ | FLT3 | P36888 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29396524 | 1.00 | MGAM (0.52) | MGAMGAASIMGAM2NTRK1 | |
| SCHEMBL29074194 | 0.92 | MGAM (0.48) | MGAMGAASIMGAM2NTRK1 | |
| SCHEMBL28417194 | 0.91 | MGAM (0.48) | MGAMGAASIMGAM2NTRK1 | |
| SCHEMBL28417192 | 0.87 | MGAM (0.47) | MGAMGAASIMGAM2NTRK1 | |
| SCHEMBL22890490 | 0.86 | MGAM (0.43) | MGAMGAASIMGAM2NTRK1 | |
| SCHEMBL29074193 | 0.82 | GAA (0.50) | MGAMGAASIMGAM2NTRK1 | |
| SCHEMBL28415732 | 0.81 | STING1 (0.42) | MGAMGAASIMGAM2NTRK1 | |
| SCHEMBL28415729 | 0.81 | NTRK1 (0.44) | MGAMGAASIMGAM2NTRK1 | |
| SCHEMBL29074192 | 0.79 | MGAM (0.47) | MGAMGAASIMGAM2NTRK1 | |
| SCHEMBL30923269 | 0.77 | MGAM (0.43) | MGAMGAASIMGAM2CDK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250191770-A1 | COMPUTERIZED DECISION SUPPORT TOOL AND MEDICAL DEVICE FOR RESPIRATORY CONDITION MONITORING AND CARE | PFIZER INC. (US) | 2025-06-12 | — | — | US | claimed |
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | claimed |
| US-20230329630-A1 | COMPUTERIZED DECISION SUPPORT TOOL AND MEDICAL DEVICE FOR RESPIRATORY CONDITION MONITORING AND CARE | PFIZER INC. (US) | 2023-10-19 | — | — | US | claimed |
| WO-2023166453-A1 | COMPUTERIZED DECISION SUPPORT TOOL AND MEDICAL DEVICE FOR RESPIRATORY CONDITION MONITORING AND CARE | PFIZER INC. (US) | 2023-09-07 | — | — | WO | claimed |
| EP-4203775-A1 | COMPUTERIZED DECISION SUPPORT TOOL AND MEDICAL DEVICE FOR RESPIRATORY CONDITION MONITORING AND CARE | Pfizer Inc. (US) | 2023-07-05 | — | — | EP | claimed |
| WO-2022047311-A1 | COMPUTERIZED DECISION SUPPORT TOOL AND MEDICAL DEVICE FOR RESPIRATORY CONDITION MONITORING AND CARE | PFIZER INC. (US) | 2022-03-03 | — | — | WO | claimed |
| US-12577240-B2 | Antiviral heteroaryl ketone derivatives | PFIZER INC. (US) | 2026-03-17 | — | — | US | disclosed |
| US-12485157-B2 | Method of treating COVID-19 | PFIZER INC. (US) | 2025-12-02 | — | — | US | disclosed |
| US-12358897-B2 | Compounds and method of treating COVID-19 | PFIZER INC. (US) | 2025-07-15 | — | — | US | disclosed |
| US-20250191770-A1 | COMPUTERIZED DECISION SUPPORT TOOL AND MEDICAL DEVICE FOR RESPIRATORY CONDITION MONITORING AND CARE | PFIZER INC. (US) | 2025-06-12 | — | — | US | disclosed |
| US-20250099424-A1 | Nitrile-Containing Antiviral Compounds | PFIZER INC. (US) | 2025-03-27 | — | — | US | disclosed |
| EP-4516301-A2 | NITRILE-CONTAINING COMPOUNDS FOR USE AS MEDICAMENTS | Pfizer Inc. (US) | 2025-03-05 | — | — | EP | disclosed |
| WO-2025037206-A1 | DEUTERATED ANTIVIRAL COMPOUNDS | PFIZER INC. (US) | 2025-02-20 | — | — | WO | disclosed |
| WO-2022013684-A1 | ANTIVIRAL HETEROARYL KETONE DERIVATIVES | PFIZER INC. (US) | 2022-01-20 | — | — | WO | disclosed |
| US-20220017548-A1 | Compounds and Methods for the Treatment of COVID-19 | PFIZER INC. (US) | 2022-01-20 | — | — | US | disclosed |
| WO-2021250648-A1 | NITRILE-CONTAINING ANTIVIRAL COMPOUNDS | PFIZER INC. (US) | 2021-12-16 | — | — | WO | disclosed |
| WO-2021176369-A1 | METHODS OF INHIBITING SARS-COV-2 REPLICATION AND TREATING CORONAVIRUS DISEASE 2019 | PFIZER INC. (US) | 2021-09-10 | — | — | WO | disclosed |
| US-20190309289-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2019-10-10 | — | — | US | disclosed |
| US-10370654-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. (US) | 2019-08-06 | — | — | US | disclosed |
| US-20180320170-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2018-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12485157-B2 | Method of treating COVID-19 | ACE2, ACE, TMPRSS2 | MGAM 279/4885GAA 293/4885SI 450/4885 |
| US-12358897-B2 | Compounds and method of treating COVID-19 | ACE2, ACE, SARS1 | MGAM 2529/4885GAA 1065/4885SI 3643/4885 |
| US-12577240-B2 | Antiviral heteroaryl ketone derivatives | ACE2, SARS1, ACE | MGAM 1880/4885GAA 1403/4885SI 3076/4885 |
| US-20250099424-A1 | Nitrile-Containing Antiviral Compounds | ACE2, NOS2, EIF2AK2 | MGAM 3437/4885GAA 2523/4885SI 3817/4885 |
| US-20220017548-A1 | Compounds and Methods for the Treatment of COVID-19 | ACE2, ACE, SARS1 | MGAM 2733/4885GAA 891/4885SI 3504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.